
European Journal of Medicinal Chemistry p. 423 - 436 (1998)
Update date:2022-08-05
Topics: Synthesis Inhibitors Catalyst Purification Reaction Conditions Activity Biological assay HIV protease
Garrouste, Patrick
Pawlowski, Macek
Tonnaire, Thierry
Sicsic, Sames
Dumy, Pascal
De Rosny, Eve
Reboud-Ravaux, Michele
Fulcrand, Pierre
Martinez, Jean
We report here the synthesis and activity of HIV protease inhibitors. In the first stage hydrophobic compounds incorporating a 'carba' bond surrogate or a beta-homologated residue were synthesized. Secondly, we synthesized cyclic compounds in which we incorporated 2-quinoline carboxylic acid in the P3 position and the amino-hydroxyindane moiety in the P'3. The last part of this work was dedicated to a structure/activity study of a peptide substrate. These modifications allowed us to work up the synthesis of new pseudopeptide bonds: amino-amide and hydroxy-amide. Compounds with activity in the micromolar range were actually a starting point for the synthesis of new protease inhibitors.
View MoreHangzhou TJM Chemical Trade Co., Ltd
Contact:86-571-88223276 86-13388481653
Address:2221#,Boyuexuan,1860# Binsheng Road,Binjiang District, Hangzhou CityZhejiang Province, 310051, P. R. China
Forsman Scientific(Beijing)co.,Ltd.
Contact:+86-10-64646565
Address:Rm No.1301, Building-2, No. A-13 Beiyuan Road, Chaoyang District Beijing, China, PR,
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
Dalian Join King Biochemical Tech. Co., Ltd.
Contact:0411 39216206
Address:814 First State Blvd
Doi:10.1016/j.ejmech.2018.11.060
(2019)Doi:10.1007/BF02232534
(1970)Doi:10.1021/jm030003x
(2003)Doi:10.1016/S0014-827X(01)01134-X
(2001)Doi:10.1107/S2053229617012761
(2017)Doi:10.1021/jo990055n
(1999)